CLINICAL_TRIALS
trial_result
· 2017-06-01
Clinical Trial Update: A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid Arthritis [Phase 2]
Summary
A long-term safety study of mavrilimumab in adults with rheumatoid arthritis (Phase 2) was terminated, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MedImmune LLC | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2017-06-01